Antimicrobial activity of some novel 2-(2-iodophenylimino)-5-arylidenethiazolidin-4-one derivatives

[1] Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997; 40:135–6.HiramatsuKHanakiHInoTYabutaKOguriTTenoverFCMethicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJ Antimicrob Chemother199740135–610.1093/jac/40.1.135Search in Google Scholar

[2] Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH. An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov. 2010; 9:719–27.Ostrosky-ZeichnerLCasadevallAGalgianiJNOddsFCRexJHAn insight into the antifungal pipeline: selected new molecules and beyondNat Rev Drug Discov20109719–2710.1038/nrd3074Search in Google Scholar

[3] Wiederhold NP, Patterson TF. What’s new in antifungals: an update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents. Curr Opin Infect Dis. 2015; 28:539–45.WiederholdNPPattersonTFWhat’s new in antifungals: an update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agentsCurr Opin Infect Dis201528539–4510.1097/QCO.0000000000000203Search in Google Scholar

[4] Abhinit M, Ghodke M, Pratima NA. Exploring potential of 4-thiazolidinone: a brief review. Int J Pharm Pharm Sci. 2009; 1:47–64.AbhinitMGhodkeMPratimaNAExploring potential of 4-thiazolidinone: a brief reviewInt J Pharm Pharm Sci2009147–64Search in Google Scholar

[5] Zhou H, Wu S, Zhai S, Liu A, Sun Y, Li R, et al. Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells. J Med Chem. 2008; 51:1242–51.ZhouHWuSZhaiSLiuASunYLiRet alDesign, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cellsJ Med Chem2008511242–5110.1021/jm7012024Search in Google Scholar

[6] Barreca ML, Chimirri A, De Luca L, Monforte AM, Monforte P, Rao A, et al. Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorg Med Chem Lett. 2001; 11:1793–6.BarrecaMLChimirriADeLuca LMonforteAMMonfortePRaoAet alDiscovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agentsBioorg Med Chem Lett2001111793–610.1016/S0960-894X(01)00304-3Search in Google Scholar

[7] Buvana C, Mahalaksmi A, Bijo M, Sukumar M. Synthesis of some thiazolidinone derivatives from indole 2-carboxylic acid and evaluation of its xanthine oxidase inhibitory and antioxidant activity. Int J ChemTech Res. 2011; 3:671–5.BuvanaCMahalaksmiABijoMSukumarMSynthesis of some thiazolidinone derivatives from indole 2-carboxylic acid and evaluation of its xanthine oxidase inhibitory and antioxidant activityInt J ChemTech Res20113671–5Search in Google Scholar

[8] Gürsoy A, Terzioğlu N. Synthesis and isolation of new regioisomeric 4-thiazolidinones and their anticonvulsant activity. Turk J Chem. 2005; 29:247–54.GürsoyATerzioğluNSynthesis and isolation of new regioisomeric 4-thiazolidinones and their anticonvulsant activityTurk J Chem200529247–54Search in Google Scholar

[9] Chavan A, Pai NR. Synthesis and antimicrobial screening of 5-aryliden-4-thiazolidinones. ARKIVOC. 2007; 16:148–55.ChavanAPaiNRSynthesis and antimicrobial screening of 5-aryliden-4-thiazolidinonesARKIVOC200716148–5510.3998/ark.5550190.0008.g16Search in Google Scholar

[10] Desai NC, Bhatt N, Kumar M, Makwana A. Synthesis, characterization and antimicrobial activity of some 3-(2-(1H-benzod imidazol-2-yl)phenyl)-2-arylthiazolidin-4-ones. Indian J Chem. 2011; 50B:941–5.DesaiNCBhattNKumarMMakwanaA. Synthesischaracterization and antimicrobial activity of some 3-(2-(1H-benzod imidazol-2-yl)phenyl)-2-arylthiazolidin-4-onesIndian J Chem201150B941–510.1002/chin.201145122Search in Google Scholar

[11] Parekh HH, Parikh KA, Parikh AR. Synthesis of some 4-thiazolidinone derivatives as antitubercular agents. J Sci IR Iran. 2004; 15:143–8.ParekhHHParikhKAParikhARSynthesis of some 4-thiazolidinone derivatives as antitubercular agentsJ Sci IR Iran200415143–8Search in Google Scholar

[12] Vicini P, Geronikaki A, Incerti M, Zani F, Dearden J, Hewitt M. 2-Heteroarylimino-5-benzylidene-4-thiazolidinones analogues of 2-thiazolylimino-5-benzylidene-4-thiazolidinones with antimicrobial activity: synthesis and structure–activity relationship. Bioorg Med Chem. 2008; 16:3714–24.ViciniPGeronikakiAIncertiMZaniFDeardenJHewittM2-Heteroarylimino-5-benzylidene-4-thiazolidinones analogues of 2-thiazolylimino-5-benzylidene-4-thiazolidinones with antimicrobial activity: synthesis and structure–activity relationshipBioorg Med Chem2008163714–2410.1016/j.bmc.2008.02.001Search in Google Scholar

[13] Vinay V, Lakshika K. A review on antimicrobial activity of 4-thiazolidinone derivatives. Int J Pharm Pharm Sci. 2011; 1:17–27.VinayVLakshikaKA review on antimicrobial activity of 4-thiazolidinone derivativesInt J Pharm Pharm Sci2011117–27Search in Google Scholar

[14] Khafagy MM, Abd El-Wahab AHF, Eid FA, El-Agrody AM. Synthesis of halogen derivatives of benzo[h]chromene and benzo[a] anthracene with promising antimicrobial activities. Il Farmaco. 2002; 57:715–22.KhafagyMMAbdEl-Wahab AHFEidFAEl-AgrodyAMSynthesis of halogen derivatives of benzohchromene and benzoa anthracene with promising antimicrobial activitiesIl Farmaco200257715–2210.1016/S0014-827X(02)01263-6Search in Google Scholar

[15] Miroslaw B, Plech T, Wujec M. Halogen bonding in the antibacterial 1,2,4-triazole-3-thione derivative – Spectroscopic properties, crystal structure and conformational analysis. J Mol Struct. 2015; 1083:187–93.MiroslawBPlechTWujecMHalogen bonding in the antibacterial 1,2,4-triazole-3-thione derivative – Spectroscopic properties, crystal structure and conformational analysisJ Mol Struct20151083187–9310.1016/j.molstruc.2014.11.060Search in Google Scholar

[16] Howe RA, Andrews JM. BSAC working party on susceptibility testing. BSAC standardized disc susceptibility testing method (version 11). J Antimicrob Chemother. 2012; 67:2783–4.HoweRAAndrewsJMBSAC working party on susceptibility testingBSAC standardized disc susceptibility testing method (version 11). J Antimicrob Chemother2012672783–410.1093/jac/dks39123095231Search in Google Scholar

[17] MacGowan AP, Wise R. Establishing MIC breakpoints and interpretation of in vitro susceptibility tests. J Antimicrob Chemother. 2001; 48(Suppl S1):17–28.MacGowanAPWiseREstablishing MIC breakpoints and interpretation of in vitro susceptibility testsJ Antimicrob Chemother200148Suppl S117–2810.1093/jac/48.suppl_1.1711420334Search in Google Scholar

[18] Montalbetti CAGN, Falque V. Amide bond formation and peptide coupling. Tetrahedron. 2005; 61:10827–52.MontalbettiCAGNFalqueVAmide bond formation and peptide couplingTetrahedron20056110827–5210.1016/j.tet.2005.08.031Search in Google Scholar

[19] Guo H, Xie F, Zhu M, Li Y, Yang Z, Wang X, et al. The synthesis of pteroyl-lys conjugates and its application as technetium-99m labeled radiotracer for folate receptor-positive tumor targeting. Bioorg Med Chem Lett. 2011; 21:2025–9.GuoHXieFZhuMLiYYangZWangXet alThe synthesis of pteroyl-lys conjugates and its application as technetium-99m labeled radiotracer for folate receptor-positive tumor targetingBioorg Med Chem Lett2011212025–910.1016/j.bmcl.2011.02.01421377880Search in Google Scholar

[20] Shelar V, Telkar R, Venkataramana CHS. Synthesis and antimicrobial activity of some novel thiazolidinone derivatives. Der Pharmacia Lettre. 2010; 2:146–54.ShelarVTelkarRVenkataramanaCHSSynthesis and antimicrobial activity of some novel thiazolidinone derivativesDer Pharmacia Lettre20102146–54Search in Google Scholar